ASC REGISTRATION PAGE

The conference will be divided into themed sessions designed to give participants a best ideas overview of core innovations in the field.

Each session will feature multiple presentations from leaders in the space working on compelling and innovative solutions for cure, treatment, and care, followed by a panel discussion.

Session highlights:

Knowing the enemy: research progress in understanding Alzheimer's.
Accurate diagnostics: diagnostic & early detection breakthroughs.
From news headlines to patients: clinical trial ready drugs.
Tech innovation: tech-based solutions for treatment & care.
Lifestyle interventions: nutrition, meditation & physical exercise.

FEATURED SPEAKERS

Howard Fillit, MD

Founding Executive Director and Chief Science Officer at the Alzheimer's Drug Discovery Foundation

George Perry, Ph.D

Chief Scientist, Brain Health Consortium, University of Texas at San Antonio

Ken Abramowitz,

Co-founder & Managing General Partner,
NGN Capital LLC.

David Weild IV

Chairman & CEO,
Weild & Co., Inc.

Hugo Geerts, Ph.D

Chief Scientific Officer,
In Silico Biosciences

Adeboye Adejare, Ph.D

Leading resercher & neuroscience professor, University of the Sciences

Rhoda Au, Ph.D

Professor, Anatomy & Neurobiology, Boston University

MARK E. GURNEY, Ph.D

Chairman & CEO,
Tetra Discovery Partners Inc.

Benoît Melchior, Ph.D

Director, Biology
Samumed, LLC

Irfan Qureshi, MD

Executive Director, Neurology
Biohaven LLC

Martin Tolar, MD

Founder & CEO, Alzheon Inc.

Daniel Alkon, MD

President and Chief Scientific Officer, Neurotrope Inc.

Sharon Rosenzweig-Lipson, Ph.D

Vice President of Research
and Development, AgeneBio Inc.

Leen Kawas, Ph.D

President and CEO,
Athira Pharma, Inc.

Julie Fleming

Founder of The Purple Sherpa, Inc.

Tamara Maes, Ph.D

Chief Scientific Officer,
Oryzon Genomics Inc.

M. Kathryn Jedrziewski, Ph.D

Deputy Director,
Institute on Aging,
Perelman School of Medicine

Matt Golden, Co-Founder & CEO

MapHabit, Inc.

Paula T. Trzepacz, MD

Chief Medical Adviser, Eltoprazine Pharma at Amarantus Biosciences Inc.

Nik Tezapsidis, PhD

Founder & CEO,
Neurotez, Inc.

For questions, please call Grace Mutavu at (212)655-9865 or email ascinfo@investacure.com

FEATURED SPEAKERS

For CME Accreditation Information - CLICK HERE